| Product Code: ETC13160393 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Temporal Arteritis Market was valued at USD 0.25 Billion in 2024 and is expected to reach USD 0.35 Billion by 2031, growing at a compound annual growth rate of 2.70% during the forecast period (2025-2031).
The Global Temporal Arteritis Market is experiencing steady growth, driven by increasing awareness of the disease among healthcare professionals and patients. Temporal arteritis, also known as giant cell arteritis, is a type of vasculitis that mainly affects the arteries in the head and neck. The market is primarily fueled by the rising prevalence of the condition, particularly among the elderly population. Key players in the market are focusing on developing innovative diagnostic tools and effective treatment options to address the unmet medical needs of patients. Additionally, advancements in healthcare infrastructure and increasing investments in research and development activities are expected to further propel the market growth. However, challenges such as limited understanding of the disease mechanism and high treatment costs may hinder market expansion in certain regions.
The Global Temporal Arteritis Market is witnessing a growing emphasis on early diagnosis and treatment to prevent vision loss and other complications associated with the condition. Biologic therapies, such as tocilizumab, are emerging as promising treatment options, providing new opportunities for market growth. Additionally, advancements in imaging technology, such as PET scans, are improving the accuracy of diagnosis and monitoring of disease progression. The market is also benefitting from increased awareness and screening efforts, leading to higher diagnosis rates. With the aging population and rising prevalence of autoimmune diseases, there is a significant market opportunity for pharmaceutical companies to develop innovative therapies and diagnostic tools for temporal arteritis. Collaborations between healthcare providers, researchers, and industry stakeholders are essential for driving further advancements in this market.
In the Global Temporal Arteritis Market, there are several challenges that stakeholders face. One significant challenge is the difficulty in accurately diagnosing temporal arteritis due to its nonspecific symptoms and the need for invasive biopsy procedures for confirmation. Additionally, the limited awareness among healthcare professionals about this rare disease often leads to delayed diagnosis and treatment initiation. Another challenge is the lack of targeted treatment options, with corticosteroids being the primary therapy despite their long-term side effects. Furthermore, the small patient population and the high cost of developing new drugs for temporal arteritis pose challenges for pharmaceutical companies in investing in research and development efforts. Overall, addressing these challenges requires collaborative efforts from healthcare providers, researchers, and policymakers to improve early detection, increase treatment options, and enhance patient outcomes in the Global Temporal Arteritis Market.
The global temporal arteritis market is primarily driven by the increasing prevalence of the condition, particularly among the elderly population. As the aging population grows worldwide, the incidence of temporal arteritis is also expected to rise, leading to a higher demand for diagnosis and treatment options. Additionally, advancements in healthcare infrastructure and technology have improved the diagnosis and management of temporal arteritis, further driving market growth. The rising awareness among healthcare providers and patients about the symptoms and complications associated with temporal arteritis is also contributing to market expansion. Moreover, ongoing research and development activities aimed at developing novel therapeutics and treatment approaches for temporal arteritis are expected to fuel market growth in the coming years.
Government policies related to the Global Temporal Arteritis Market typically focus on ensuring patient access to necessary treatments, promoting research and development for new therapies, and regulating the quality and safety of medications. Policies may include providing reimbursement for approved treatments, funding research initiatives to advance understanding of the disease, and implementing regulations to oversee drug manufacturing and distribution processes. Government agencies and health authorities also collaborate with healthcare providers and industry stakeholders to address challenges in diagnosis, treatment, and patient care for individuals affected by Temporal Arteritis. Overall, these policies aim to improve outcomes for patients, support innovation in healthcare, and maintain high standards of care within the Global Temporal Arteritis Market.
The Global Temporal Arteritis Market is expected to witness steady growth in the coming years due to factors such as an aging population, increasing awareness about the condition, and advancements in diagnosis and treatment options. The rising prevalence of autoimmune diseases, which often coexist with temporal arteritis, is also likely to drive market growth. Additionally, ongoing research efforts aimed at developing new therapies and improving existing treatment strategies are anticipated to further propel the market forward. However, challenges such as the high cost of treatment and limited availability of targeted therapies may hinder market expansion to some extent. Overall, the Global Temporal Arteritis Market is poised for growth, with opportunities for innovation and market entry for pharmaceutical companies and healthcare providers.
In the Global Temporal Arteritis Market, each region exhibits unique trends. Asia shows a growing prevalence of temporal arteritis due to an aging population and increasing awareness among healthcare professionals. North America leads in terms of market share, driven by advanced healthcare infrastructure and high diagnosis rates. Europe also has a significant market presence, with a focus on research and development of innovative treatments. The Middle East and Africa region is witnessing a gradual rise in temporal arteritis cases, attributed to improving healthcare access and awareness. Latin America presents opportunities for market growth, supported by increasing healthcare investments and rising awareness about the condition. Overall, regional insights in the Global Temporal Arteritis Market indicate varying levels of market maturity and potential for expansion.
Global Temporal Arteritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Temporal Arteritis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Temporal Arteritis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Temporal Arteritis Market - Industry Life Cycle |
3.4 Global Temporal Arteritis Market - Porter's Five Forces |
3.5 Global Temporal Arteritis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Temporal Arteritis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Temporal Arteritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Temporal Arteritis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Temporal Arteritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Temporal Arteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Temporal Arteritis Market Trends |
6 Global Temporal Arteritis Market, 2021 - 2031 |
6.1 Global Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Temporal Arteritis Market, Revenues & Volume, By Corticosteroids, 2021 - 2031 |
6.1.3 Global Temporal Arteritis Market, Revenues & Volume, By Aristocort, 2021 - 2031 |
6.1.4 Global Temporal Arteritis Market, Revenues & Volume, By Bubbli-Pred, 2021 - 2031 |
6.1.5 Global Temporal Arteritis Market, Revenues & Volume, By Immunosuppressive Agents, 2021 - 2031 |
6.1.6 Global Temporal Arteritis Market, Revenues & Volume, By Adalimumab, 2021 - 2031 |
6.1.7 Global Temporal Arteritis Market, Revenues & Volume, By Infliximab, 2021 - 2031 |
6.1.8 Global Temporal Arteritis Market, Revenues & Volume, By Anticoagulants, 2021 - 2031 |
6.2 Global Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Temporal Arteritis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Temporal Arteritis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3 Global Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Temporal Arteritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Temporal Arteritis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.4 Global Temporal Arteritis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.5 Global Temporal Arteritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Temporal Arteritis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Temporal Arteritis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.4.4 Global Temporal Arteritis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Temporal Arteritis Market, Overview & Analysis |
7.1 North America Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Temporal Arteritis Market, Overview & Analysis |
8.1 Latin America (LATAM) Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Temporal Arteritis Market, Overview & Analysis |
9.1 Asia Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Temporal Arteritis Market, Overview & Analysis |
10.1 Africa Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Temporal Arteritis Market, Overview & Analysis |
11.1 Europe Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Temporal Arteritis Market, Overview & Analysis |
12.1 Middle East Temporal Arteritis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Temporal Arteritis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Temporal Arteritis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Temporal Arteritis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Temporal Arteritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Temporal Arteritis Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Temporal Arteritis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Temporal Arteritis Market Key Performance Indicators |
14 Global Temporal Arteritis Market - Export/Import By Countries Assessment |
15 Global Temporal Arteritis Market - Opportunity Assessment |
15.1 Global Temporal Arteritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Temporal Arteritis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Temporal Arteritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Temporal Arteritis Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Temporal Arteritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Temporal Arteritis Market - Competitive Landscape |
16.1 Global Temporal Arteritis Market Revenue Share, By Companies, 2024 |
16.2 Global Temporal Arteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here